SynopsisCovid-19 Antigen Test Kits The global Covid-19 Antigen Test Kits market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Covid-.....
SynopsisAdjuvant is an integral part of a vaccine that helps to develop strong immune response in the human body. Conventional vaccines are derived from toxin, inactivated whole organism, and live-attenuated, which are effective in stimulating antibody-based immunity......
SynopsisThe global Speculum market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Speculum is estimated to increase from $ million in 2023 .....
Synopsis Due to the COVID-19 pandemic, the global Monitoring Electrodes market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully cons.....
SynopsisGlobal Bionic Arm market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great .....
SynopsisHome Fill or Transfill Oxygen Systems provide clients greater independence and freedom by allowing individuals to re-fill their portable oxygen cylinders as they need them, in their home, eliminating the need to wait for cylinder deliveries or curtail activity.....
SynopsisWheeled Examination Lamp so constructed that an intense light is emitted through a slit; used for examination of the eye. The global Wheeled Examination Lamps market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witne.....
SynopsisReceptor Tyrosine-protein Kinase ERBB 3 ELISA Kit is an experimental tool used to detect the protein content of receptor tyrosine-protein kinase ERBB 3 in samples. The global Receptor Tyrosine-protein Kinase ERBB 3 ELISA Kit market was valued at US$ 10 m.....
SynopsisPegfilgrastim is developed by PEGylating the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue, filgrastim. Pegfilgrastim was first launched by Amgen Inc. as Neulasta in 2002. Later, several biosimilars of pegfilgrastim were launched in .....
Synopsis The global Genomic Biomarkers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Genomic Biomarkers is estima.....
